Fenofibrate Tablet, Coated
Product Images NDC 82009-060

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 82009-060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (145 mg (90 Tablet Bottle))

Package Label-principal Display Panel (145 mg (90 Tablet Bottle))
Each tablet of this medication contains 145 mg of Fenofibrate USP. It is manufactured and distributed by Aurobindo Pharma Limited from India. This medicine should be stored in a dry place at room temperature (20°C to 25°C). It is important to protect the container from moisture and not to use it if the seal is broken or missing. The packaging should include a package insert with the full prescribing information. The medicine should be dispensed using a USP tight container, and it is assigned the Rx only identifier P1431242. The labeling includes a unique identifier (GTIN), serial number (SN), expiry date (EXP), and LOT number, which will be printed during packaging.*
FDA Label Image

Chemical Structure (Fenofibrate Str)

Chemical Structure (Fenofibrate Str)
This text appears to be not-available as it is just one character and does not provide any meaningful information to generate a description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.